University of Cambridge > Talks.cam > Worms and Bugs > Estimating the impact of SARS-CoV-2 lineage B.1.1.7 on mortality due to COVID-19 in the UK

Estimating the impact of SARS-CoV-2 lineage B.1.1.7 on mortality due to COVID-19 in the UK

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Dr Ciara Dangerfield.

The B.1.1.7 lineage of SARS -CoV-2 was first identified in the South East of England during the Autumn of 2020. It is more transmissible than previously circulating variants and spread rapidly despite the second national lockdown in November. Over the same period hospital services were under immense pressure and the NHS was at risk of being over-whelmed. particularly in intensive care. Issues with hospital capacity are known to increase mortality. We conducted a matched cohort study to examine the independent effect of B.1.1.7 infection on mortality against this complex and shifting background of risks and biases.

This talk is part of the Worms and Bugs series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2021 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity